Aerovate Therapeutics (AVTE)
(Real Time Quote from BATS)
$1.89 USD
-0.05 (-2.58%)
Updated Sep 6, 2024 11:34 AM ET
2-Buy of 5 2
D Value D Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/11/24 |
---|---|
Current Quarter | -0.59 |
EPS Last Quarter | -0.86 |
Last EPS Surprise | -13.16% |
ABR | 3.00 |
Earnings ESP
|
-5.09% |
---|---|
Current Year | -2.74 |
Next Year | -0.88 |
EPS (TTM) | -3.14 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.59 | -0.49 | -2.74 | -0.88 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | -0.62 | -0.60 | -2.91 | -1.13 |
High Estimate | -0.56 | -0.37 | -2.57 | -0.63 |
Low Estimate | -0.62 | -0.60 | -2.91 | -1.13 |
Year ago EPS | -0.71 | -0.74 | -2.87 | -2.74 |
Year over Year Growth Est. | 16.90% | 33.78% | 4.53% | 67.88% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 1 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.59 | -0.49 | -2.74 | -0.88 |
7 Days Ago | -0.59 | -0.49 | -2.74 | -0.88 |
30 Days Ago | -0.64 | -0.55 | -2.79 | -1.20 |
60 Days Ago | -0.64 | -0.55 | -2.87 | -1.15 |
90 Days Ago | -0.67 | -0.62 | -2.94 | -2.71 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.62 | -0.60 | -2.91 | -1.13 |
Zacks Consensus Estimate | -0.59 | -0.49 | -2.74 | -0.88 |
Earnings ESP | -5.09% | -23.71% | -6.20% | -28.41% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.86 | -0.83 | -0.74 | -0.71 | NA |
Estimate | -0.76 | -0.74 | -0.68 | -0.70 | NA |
Difference | -0.10 | -0.09 | -0.06 | -0.01 | -0.07 |
Surprise | -13.16% | -12.16% | -8.82% | -1.43% | -8.89% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more